vs
Side-by-side financial comparison of CME Group (CME) and Garden Stage Ltd (GSIW). Click either name above to swap in a different company.
CME Group is the larger business by last-quarter revenue ($1.9B vs $704.3K, roughly 2669.3× Garden Stage Ltd). CME Group runs the higher net margin — 0.1% vs -464.9%, a 465.0% gap on every dollar of revenue. On growth, CME Group posted the faster year-over-year revenue change (14.5% vs 0.0%).
CME Group Inc. is an American financial services company based in Chicago, Illinois. It operates financial derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX), and the Commodity Exchange (COMEX). The company owns 27% of S&P Dow Jones Indices. It is the world's largest operator of financial derivatives exchanges. Its exchanges are platforms for trading in agricultural products, currencies, energy, i...
Virginia Stage Company (VSC) is a professional theater company located in Hampton Roads, Virginia. VSC presents locally produced plays for over 70,000 patrons a year both at the Wells Theatre in Norfolk, Virginia and throughout the community. A nonprofit theater, VSC has developed their "American Soil Series," a program that commissions plays of special regional interest, usually receiving their world premieres.
CME vs GSIW — Head-to-Head
Income Statement — Q1 2026 vs Q2 2026
| Metric | | |
|---|---|---|
| Revenue | $1.9B | $704.3K |
| Net Profit | $1.2M | $-3.3M |
| Gross Margin | — | — |
| Operating Margin | 0.1% | — |
| Net Margin | 0.1% | -464.9% |
| Revenue YoY | 14.5% | 0.0% |
| Net Profit YoY | 20.7% | 0.0% |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.9B | — | ||
| Q4 25 | $1.6B | — | ||
| Q3 25 | $1.5B | $704.3K | ||
| Q2 25 | $1.7B | — | ||
| Q1 25 | $1.6B | — | ||
| Q4 24 | $1.5B | — | ||
| Q3 24 | $1.6B | $1.2M | ||
| Q2 24 | $1.5B | — |
| Q1 26 | $1.2M | — | ||
| Q4 25 | $1.2B | — | ||
| Q3 25 | $908.0M | $-3.3M | ||
| Q2 25 | $1.0B | — | ||
| Q1 25 | $956.2M | — | ||
| Q4 24 | $874.6M | — | ||
| Q3 24 | $912.8M | $-3.3M | ||
| Q2 24 | $883.2M | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 77.4% | ||
| Q2 24 | — | — |
| Q1 26 | 0.1% | — | ||
| Q4 25 | 61.8% | — | ||
| Q3 25 | 63.3% | — | ||
| Q2 25 | 66.7% | — | ||
| Q1 25 | 67.5% | — | ||
| Q4 24 | 62.1% | — | ||
| Q3 24 | 64.6% | -277.9% | ||
| Q2 24 | 65.3% | — |
| Q1 26 | 0.1% | — | ||
| Q4 25 | 71.7% | — | ||
| Q3 25 | 59.1% | -464.9% | ||
| Q2 25 | 60.6% | — | ||
| Q1 25 | 58.2% | — | ||
| Q4 24 | 57.3% | — | ||
| Q3 24 | 57.6% | -277.5% | ||
| Q2 24 | 57.6% | — |
| Q1 26 | — | — | ||
| Q4 25 | $3.24 | — | ||
| Q3 25 | $2.49 | — | ||
| Q2 25 | $2.81 | — | ||
| Q1 25 | $2.62 | — | ||
| Q4 24 | $2.40 | — | ||
| Q3 24 | $2.50 | $0.21 | ||
| Q2 24 | $2.42 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.4B | — |
| Total DebtLower is stronger | $3.4B | — |
| Stockholders' EquityBook value | — | $6.7M |
| Total Assets | $202.0B | $15.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $2.4B | — | ||
| Q4 25 | $4.5B | — | ||
| Q3 25 | $2.6B | — | ||
| Q2 25 | $2.1B | — | ||
| Q1 25 | $1.5B | — | ||
| Q4 24 | $3.0B | — | ||
| Q3 24 | $2.4B | — | ||
| Q2 24 | $1.9B | — |
| Q1 26 | $3.4B | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | $28.7B | — | ||
| Q3 25 | $28.2B | $6.7M | ||
| Q2 25 | $27.7B | — | ||
| Q1 25 | $27.0B | — | ||
| Q4 24 | $26.5B | — | ||
| Q3 24 | $28.2B | $6.9M | ||
| Q2 24 | $27.6B | — |
| Q1 26 | $202.0B | — | ||
| Q4 25 | $198.4B | — | ||
| Q3 25 | $187.1B | $15.9M | ||
| Q2 25 | $179.9B | — | ||
| Q1 25 | $157.8B | — | ||
| Q4 24 | $137.4B | — | ||
| Q3 24 | $137.8B | $15.6M | ||
| Q2 24 | $123.4B | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-809.6K |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $1.1B | — | ||
| Q3 25 | $968.1M | $-809.6K | ||
| Q2 25 | $1.1B | — | ||
| Q1 25 | $1.1B | — | ||
| Q4 24 | $1.0B | — | ||
| Q3 24 | $1.0B | $-809.6K | ||
| Q2 24 | $776.9M | — |
| Q1 26 | — | — | ||
| Q4 25 | $1.1B | — | ||
| Q3 25 | $949.7M | — | ||
| Q2 25 | $1.0B | — | ||
| Q1 25 | $1.1B | — | ||
| Q4 24 | $991.7M | — | ||
| Q3 24 | $973.2M | $-1.0M | ||
| Q2 24 | $758.7M | — |
| Q1 26 | — | — | ||
| Q4 25 | 66.8% | — | ||
| Q3 25 | 61.8% | — | ||
| Q2 25 | 61.5% | — | ||
| Q1 25 | 67.1% | — | ||
| Q4 24 | 65.0% | — | ||
| Q3 24 | 61.4% | -87.1% | ||
| Q2 24 | 49.5% | — |
| Q1 26 | — | — | ||
| Q4 25 | 2.0% | — | ||
| Q3 25 | 1.2% | — | ||
| Q2 25 | 1.1% | — | ||
| Q1 25 | 0.9% | — | ||
| Q4 24 | 1.7% | — | ||
| Q3 24 | 1.9% | 18.5% | ||
| Q2 24 | 1.2% | — |
| Q1 26 | — | — | ||
| Q4 25 | 0.96× | — | ||
| Q3 25 | 1.07× | — | ||
| Q2 25 | 1.03× | — | ||
| Q1 25 | 1.17× | — | ||
| Q4 24 | 1.16× | — | ||
| Q3 24 | 1.10× | — | ||
| Q2 24 | 0.88× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
